British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	CASPS - CEDIRANIB IN ASPS
Description	Phase II study of cediranib (AZD2171) in the treatment of patients with alveolar soft part sarcoma
Reference	NCRN portfolio ISCRTN 63733470
Status / Sites	Open London (Royal Marsden), Manchester, Bristol
UK Chief Investigator Contact	Prof Ian Judson, London

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.